undamentalytics Newsletter
Sign in

Maxlinear, Inc (MXL) stock

Add to watchlist

Add holding +

NASDAQ: MXL Nasdaq Semiconductors Next results ~January 28, 2027

C+ Fundamentals grade

Maxlinear, Inc is a US-listed company in the semiconductors industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$45

Valuation models combined (4)

Base case. Range ~$18–$65. Weighted average of 4 models (growth cash-flow model, forward price-to-earnings vs peers, forward price-to-sales vs peers, revenue-to-maturity model), the growth cash-flow model counting double.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Maxlinear, Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 8 selling0 purchases and 30 sales by directors and officers, last 12 monthsInsider trades
  • Funds310 adding, 131 cuttingOf 63 active managers that changed their stake, 32 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Maxlinear files

Where Maxlinear stands after its latest 10-Q

Revenue for the twelve months to September 2026 was $661m, up 56.0% on a year earlier, faster than the 50.5% growth a quarter earlier. That growth ranks 6 of 43 among the semiconductor companies we cover. Free-cash-flow margin rose to -3.1% from -7.0% a year earlier. Operating margin widened to -0.9% from -36.2%. The diluted share count is up 7.7% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 4 of our 7 financial-health checks. Our revenue-to-maturity cash-flow model value is $18.45 a share, against a share price of $71.94.

Source: 10-Q filed October 22, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 28, 2027 (estimated)

Maxlinear, Inc's trailing-twelve-month revenue grew 56.0% year on year, with a free-cash-flow margin of -3.1%. Where it stands out: revenue growth of 56.0% ranks 10 of 75 semiconductor companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 30.6% while net income grew 83.6%: a 53pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 56.0% over the last 12 months, against a median of 13.7% for semiconductor companies we cover.
  • Growth speeding up. The growth rate is 5.5 points higher than a quarter earlier.
  • Margins widening. Operating margin is up 35.3 points on a year ago.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 66.4% over 90 days.

Things to watch

  • Loss-making. Operating margin is -0.9%: costs exceed revenue.
  • Burning cash. Free cash flow was -3.1% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 7.7% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 128% and a beta of 3.9 against the S&P 500.
  • Insiders selling. 8 insiders sold $60M of stock over the past 365 days and none bought (1% under pre-set trading plans).

Latest results: FY2026 Q3

Filed October 22, 2026
Earnings per share
$0.62 against an average estimate of $0.56: beat by 11.1%
Revenue
$218m, up 72.4% on a year earlier
Share reaction
-16.3% in the first session after the results on October 22, 2026, against -1.7% for the S&P 500
Next report
October 22, 2026; average EPS estimate $0.79

Maxlinear's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-9.1%
  • 1 week-7.7%
  • 1 month-42.1%
  • This year+251.9%
  • 1 year+304.8%
  • 5 years-9.6%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$661M
Operating margin
-0.9%
Net margin
-4.4%
EPS (TTM, diluted)
$-0.32

Growth

Revenue growth
+56.0%
Change in growth rate
+5.5 pts
Share count change
+7.7%

Cash

Free cash flow (TTM)
-$20.6M
FCF margin
-3.1%
Stock pay % of revenue
13.2%

Earnings

Last results
October 22, 2026
Next results (est.)
January 28, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Insider trade
  3. Insider trade
  4. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Maxlinear, Inc valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Maxlinear, Inc as an operating company, with every model that fits that kind of business. Cost of equity 14%: the 10-year Treasury yield (4.9%) plus a beta of 2.03 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$52 ~$28–$74 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$65 ~$61–$110 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$31 ~$30–$93 Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$18 ~$14–$23 Included
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$45 ~$18–$65 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Maxlinear, Inc with Semiconductors in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$14.73$21.80$26.42$17.60$21.22$38.19$75.39$33.95$23.77$19.78$17.43$61.33
Market value$786m$1.5bn$1.8bn$1.2bn$1.5bn$2.8bn$6.0bn$2.7bn$1.9bn$1.7bn$1.5bn$5.7bn
+ Net debt (− = net cash)−$68m−$81m$276m$183m$119m$221m$179m−$62m−$62m$6m$52m$84m
Enterprise value$718m$1.4bn$2.0bn$1.4bn$1.6bn$3.0bn$6.2bn$2.7bn$1.9bn$1.7bn$1.6bn$5.8bn
Multiples
Price / sales 2.6x3.8x4.2x3.1x4.8x5.8x6.7x2.5x2.8x4.6x3.2x8.6x
Price / earnings —24.1x————143.1x22.0x————
Price / free cash flow 15.1x13.6x25.9x12.7x21.1x45.7x46.5x7.9x64.1x—n/m—
EV / EBITDA —15.5x45.0x23.2x36.7x—39.4x10.3x55.8x——178.2x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

64 /100

Moderate moat

How hard Maxlinear's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 16.4% of total assets over 10 years.

  • Pricing power 17 / 20

    Gross margin has been a median 53.4%, moving by 3.2 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -2.7%; its worst year was -56.9%.

  • Cash conversion 15 / 20

    Free cash flow was positive in 7 of 10 years, at a median 15.4% of revenue.

  • Discipline 2 / 20

    The diluted share count rose 18.8% over five years; stock-based pay has been a median 8.7% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.99 +543% $774m +66%
Next $4.30 +116% $1.3bn +64%

Next year's EPS estimate has moved +66.4% in 90 days, across 11 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +13.8% on 90 days ago. In the last 30 days, 8 analysts raised Maxlinear, Inc's forecast and 0 cut it.

Consensus EPS forecast Maxlinear, Inc, last 90 days
$1.00 $2.00 $3.00 $4.00 $5.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $1.75 Current fiscal year, 60 days ago: $1.75 Current fiscal year, 30 days ago: $1.75 Current fiscal year, 7 days ago: $1.75 Current fiscal year, Now: $1.99 $1.99 Next fiscal year, 90 days ago: $2.58 Next fiscal year, 60 days ago: $2.58 Next fiscal year, 30 days ago: $2.61 Next fiscal year, 7 days ago: $2.61 Next fiscal year, Now: $4.30 $4.30

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $1.75$2.58
60 days ago $1.75$2.58
30 days ago $1.75$2.61
7 days ago $1.75$2.61
Now $1.99$4.30

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $0.56 $0.62 +11.1%
Jun 2026 $0.33 $0.35 +6.2%
Mar 2026 $0.18 $0.22 +25.6%
Dec 2025 $0.18 $0.19 +6.3%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

11 analysts, Oct 2026
Buy764%
Hold436%
Sell00%

Monthly trend

  1. Oct 202616411
  2. Sep 202616411
  3. Aug 202616411
  4. Jul 202616411

Counts of recommendations published by analysts covering Maxlinear, Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.9%
of tradable shares
Days to cover
1.36
at average volume
Short interest, 1 month
−8%
to October 15, 2026
Held by institutions
84%
of shares
Held by insiders
5.9%
of shares
Employees
1,115
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +304.8%

$15.15 on October 31, 2025 to $61.33

ThenNowEffect
Revenue (last 12 months) $378m $569m +50.5%
P/S multiple 3.4x 9.7x +183.9%
Share count 85m 90m −5.3%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years +259.9%

$17.04 on November 3, 2023 to $61.33

ThenNowEffect
Revenue (last 12 months) $1.0bn $569m −43.6%
P/S multiple 1.4x 9.7x +607.2%
Share count 81m 90m −9.8%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
MXL+97%−55%−30%−17%−12%+252%
Industry peers (median)+35%−34%+16%−9%+19%+13%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
MXL75%25%50%42%50%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
MXL−27%−61%−67%−56%−63%−55%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 88% from December 27, 2021 to April 8, 2025. Getting back needed a 742% gain, reached on May 1, 2026, 388 days after the low.

Price behaviour

52-week range
$13.05 – $128.03
From 52-week high
−52.1%
vs 50-day average
−20.4%
vs 200-day average
+1.9%
Volatility (1 year)
128%
Beta vs S&P 500
3.89

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
3 up, 9 down
typical move ±18.4%
After a week
3 up, 9 down
typical move ±20.5%
After a month
3 up, 8 down
typical move ±32.6%
Results releasedNext dayS&P 500 next day5 days21 days
October 22, 2026 −16.3% −1.7% −5.5% —
July 23, 2026 −17.5% −1.1% −22.9% −23.3%
April 23, 2026 +78.0% +0.4% +108.8% +192.6%
January 29, 2026 −9.4% −0.5% −10.6% −6.0%
October 23, 2025 −6.9% +1.4% −9.1% −19.0%
July 23, 2025 +11.7% +0.9% +10.0% −1.9%
April 23, 2025 −7.3% +3.7% −4.0% +12.1%
January 29, 2025 −14.7% +0.1% −8.0% −28.6%
October 23, 2024 +4.1% −0.7% +1.0% +8.6%
July 24, 2024 −40.3% −2.8% −39.8% −47.6%
April 24, 2024 −0.5% −0.4% −8.6% −12.8%
January 31, 2024 −13.9% −0.3% −18.0% −5.6%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Maxlinear, Inc in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Maxlinear, Inc
$300M $400M $500M $600M $700M FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $693.3M Revenue (TTM), FY24 Q1: $540.1M Revenue (TTM), FY24 Q2: $448.1M Revenue (TTM), FY24 Q3: $393.7M Revenue (TTM), FY24 Q4: $360.5M Revenue (TTM), FY25 Q1: $361.2M Revenue (TTM), FY25 Q2: $378M Revenue (TTM), FY25 Q3: $423.4M Revenue (TTM), FY25 Q4: $467.6M Revenue (TTM), FY26 Q1: $508.9M Revenue (TTM), FY26 Q2: $568.9M Revenue (TTM), FY26 Q3: $660.5M $660.5M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $693.3M
FY24 Q1 $540.1M
FY24 Q2 $448.1M
FY24 Q3 $393.7M
FY24 Q4 $360.5M
FY25 Q1 $361.2M
FY25 Q2 $378M
FY25 Q3 $423.4M
FY25 Q4 $467.6M
FY26 Q1 $508.9M
FY26 Q2 $568.9M
FY26 Q3 $660.5M
Revenue growth, TTM YoY Maxlinear, Inc
-100% -50% 0% 50% 100% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -38.1% Revenue growth, TTM YoY, FY24 Q1: -51.1% Revenue growth, TTM YoY, FY24 Q2: -55.6% Revenue growth, TTM YoY, FY24 Q3: -54.1% Revenue growth, TTM YoY, FY24 Q4: -48.0% Revenue growth, TTM YoY, FY25 Q1: -33.1% Revenue growth, TTM YoY, FY25 Q2: -15.6% Revenue growth, TTM YoY, FY25 Q3: 7.5% Revenue growth, TTM YoY, FY25 Q4: 29.7% Revenue growth, TTM YoY, FY26 Q1: 40.9% Revenue growth, TTM YoY, FY26 Q2: 50.5% Revenue growth, TTM YoY, FY26 Q3: 56.0% 56.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -38.1%
FY24 Q1 -51.1%
FY24 Q2 -55.6%
FY24 Q3 -54.1%
FY24 Q4 -48.0%
FY25 Q1 -33.1%
FY25 Q2 -15.6%
FY25 Q3 7.5%
FY25 Q4 29.7%
FY26 Q1 40.9%
FY26 Q2 50.5%
FY26 Q3 56.0%
Operating margin (TTM) Maxlinear, Inc
-80% -60% -40% -20% 0% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: -5.5% Operating margin (TTM), FY24 Q1: -25.9% Operating margin (TTM), FY24 Q2: -39.0% Operating margin (TTM), FY24 Q3: -56.9% Operating margin (TTM), FY24 Q4: -62.0% Operating margin (TTM), FY25 Q1: -53.9% Operating margin (TTM), FY25 Q2: -47.3% Operating margin (TTM), FY25 Q3: -36.2% Operating margin (TTM), FY25 Q4: -27.1% Operating margin (TTM), FY26 Q1: -19.3% Operating margin (TTM), FY26 Q2: -13.6% Operating margin (TTM), FY26 Q3: -0.9% -0.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 -5.5%
FY24 Q1 -25.9%
FY24 Q2 -39.0%
FY24 Q3 -56.9%
FY24 Q4 -62.0%
FY25 Q1 -53.9%
FY25 Q2 -47.3%
FY25 Q3 -36.2%
FY25 Q4 -27.1%
FY26 Q1 -19.3%
FY26 Q2 -13.6%
FY26 Q3 -0.9%
FCF margin (TTM) Maxlinear, Inc
-30% -20% -10% 0% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 4.3% FCF margin (TTM), FY24 Q1: 0.1% FCF margin (TTM), FY24 Q2: -6.8% FCF margin (TTM), FY24 Q3: -12.9% FCF margin (TTM), FY24 Q4: -17.5% FCF margin (TTM), FY25 Q1: -23.3% FCF margin (TTM), FY25 Q2: -18.2% FCF margin (TTM), FY25 Q3: -7.0% FCF margin (TTM), FY25 Q4: 1.5% FCF margin (TTM), FY26 Q1: 2.0% FCF margin (TTM), FY26 Q2: 0.6% FCF margin (TTM), FY26 Q3: -3.1% -3.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 4.3%
FY24 Q1 0.1%
FY24 Q2 -6.8%
FY24 Q3 -12.9%
FY24 Q4 -17.5%
FY25 Q1 -23.3%
FY25 Q2 -18.2%
FY25 Q3 -7.0%
FY25 Q4 1.5%
FY26 Q1 2.0%
FY26 Q2 0.6%
FY26 Q3 -3.1%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 51 69 72 98 120 133 300 388 420 385 317 479 892 1,120 693 361 468 661
Gross profit 34 47 45 61 73 82 155 230 208 209 168 213 496 650 386 195 266 383
EBITDA 5 5 −12 −10 −9 −4 −3 90 45 60 44 −25 157 261 33 −169 −83 32
Operating income 5 4 −15 −13 −12 −9 −44 63 −22 −19 −22 −101 65 180 −38 −223 −127 −6
Net income 4 10 −22 −13 −13 −7 −42 61 −9 −26 −20 −99 42 125 −73 −245 −137 −29
Diluted EPS $0.06 $0.30 −$0.68 −$0.40 −$0.37 −$0.19 −$0.79 $0.91 −$0.14 −$0.38 −$0.28 −$1.35 $0.53 $1.55 −$0.91 −$2.93 −$1.58 −$0.32
Growth (year on year)
Revenue — +33.8% +4.7% +35.9% +22.4% +11.3% +125.6% +29.1% +8.4% −8.4% −17.6% +50.9% +86.5% +25.5% −38.1% −48.0% +29.7% +56.0%
EBITDA — −1.0% −322.6% — — — — — −49.8% +33.0% −26.0% −155.5% — +66.2% −87.2% −608.2% — —
Operating income — −23.7% −531.7% — — — — — −134.4% — — — — +176.3% −121.2% — — —
Net income — +133.6% −317.8% — — — — — −115.0% — — — — +197.9% −158.5% — — —
Diluted EPS — +400.0% −326.7% — — — — — −115.4% — — — — +192.5% −158.7% — — —
Margins
Gross margin 66.8% 68.6% 62.9% 62.1% 61.0% 61.6% 51.7% 59.3% 49.5% 54.2% 52.9% 44.5% 55.6% 58.0% 55.6% 54.0% 56.8% 58.0%
EBITDA margin 10.6% 7.8% −16.6% −9.8% −7.2% −2.8% −1.0% 23.1% 10.7% 15.6% 14.0% −5.1% 17.6% 23.3% 4.8% −46.9% −17.7% 4.9%
Operating margin 8.9% 5.1% −21.0% −13.4% −10.3% −6.7% −14.5% 16.3% −5.2% −5.0% −7.0% −21.1% 7.3% 16.1% −5.5% −62.0% −27.1% −0.9%
Net margin 8.4% 14.7% −30.6% −13.6% −10.6% −5.3% −14.1% 15.8% −2.2% −6.8% −6.3% −20.6% 4.7% 11.2% −10.6% −68.0% −29.2% −4.4%
Free-cash-flow margin 16.5% 2.7% −14.0% 2.5% 8.1% 2.6% 17.3% 28.1% 16.1% 24.6% 22.5% 12.8% 14.5% 31.0% 4.3% −17.5% 1.5% −3.1%
Cash flow
Cash from operations 10 5 −7 8 13 12 55 117 75 103 78 74 168 389 43 −45 20 −7
Capital spending 1 3 3 5 3 9 3 9 7 8 7 12 39 41 13 18 13 13
Free cash flow 8 2 −10 2 10 3 52 109 68 95 71 61 129 347 30 −63 7 −21
Stock-based pay 1 4 7 10 13 15 19 22 33 32 32 48 59 82 55 66 77 87
Free cash flow after stock pay 7 −2 −17 −7 −3 −12 33 87 35 63 39 14 70 266 −25 −129 −70 −108
Balance sheet
Cash 18 22 28 22 26 21 68 81 72 73 93 149 131 187 187 119 73 81
Total debt 0 0 0 0 0 0 0 0 348 256 212 370 310 125 125 125 125 165
Net debt (negative = net cash) −18 −22 −28 −22 −26 −21 −68 −81 276 183 119 221 179 −62 −62 6 52 84
Diluted shares 12m 29m 33m 33m 34m 36m 53m 68m 66m 68m 71m 73m 80m 81m 81m 84m 87m 92m
Returned to shareholders
Buybacks — — 0 12 0 0 0 0 0 0 0 0 24 32 0 0 20 —
Total returned — — 0 12 0 0 0 0 0 0 0 0 24 32 0 0 20 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

4 of 7 checks passed · September 30, 2026
What it owns · $916m
Short-term assets $391mLonger-term assets $525m
What it owes, and who funded it · $916m
Short-term liabilities $176mLonger-term liabilities $207mShareholders' equity $533m
  • Short-term assets cover short-term liabilities $391m of assets due within a year against $176m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $391m short-term assets against $207m of longer-dated liabilities.
  • More cash than debt $81m of cash against $164m of debt.
  • Debt below 40% of shareholders' equity Debt is 31% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 54% to 31% over five years.
  • A year's operating cash flow covers at least 20% of debt −$7m of operating cash flow against $164m of debt.
  • Operating profit covers interest at least five times over Operating income of −$6m against $10m of interest.

From Maxlinear, Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Buybacks, last 3 fiscal years
$20M
Diluted share count
+7.7%
year over year
R&D spending
33.5%
of revenue
Sales & admin spending
25.3%
of revenue
Days sales outstanding
41 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in semiconductors
Last 12 months unless stated MXL DQ LSCC AOSL IMOS RMBS Median
Revenue, last 12 months $661m $665m $651m $679m $769m $796m $1.1bn
Revenue growth, last 12 months 56.0% −35.3% 33.3% −2.5% 8.8% 17.3% 13.7%
Revenue growth, 3-year average −8.4% 82.8% −3.4% −0.6% — 20.0% 3.9%
Revenue growth, latest quarter 72.4% — 62.2% −3.5% — 22.3% 20.1%
Gross margin 58.0% −20.7% 69.0% 22.3% 10.8% 79.1% 48.3%
Operating margin −0.9% −40.6% 7.4% −6.4% 4.8% 36.3% 4.8%
Operating margin, 3-year average −31.3% 20.8% 10.3% −3.7% 12.5% 34.6% 4.8%
Net margin −4.4% −25.6% 5.6% −6.2% 2.3% 33.4% 5.3%
Cash from operations / revenue −1.1% 7.5% 37.4% −2.4% 16.7% 43.6% 17.4%
Free-cash-flow margin −3.1% −18.5% 30.6% −10.0% 0.6% 39.3% 9.6%
Free-cash-flow margin, 3-year average −7.7% 4.7% 29.2% −4.3% 1.0% 40.4% 8.5%
Stock pay / revenue 13.2% 8.4% 18.7% 3.9% 0.2% 7.4% 5.8%
Change in share count 7.7% 1.8% 0.8% 1.9% −2.9% 0.9% 0.9%

Median of all 75 companies we cover in semiconductors. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

75 semiconductor companies
Measure Company Peer median Rank
Revenue growth Growth 56.0% 13.7% 10 of 75
Change in growth rate Growth +5.5pp +3.7pp 29 of 75
Gross margin Profitability 58.0% 48.3% 21 of 73
Operating margin Profitability -0.9% 4.8% 48 of 75
Net margin Profitability -4.4% 5.3% 49 of 75
Free-cash-flow margin Cash generation -3.1% 9.6% 55 of 75
Stock pay as % of revenue Cash generation 13.2% 6.4% 52 of 74
Long-term debt as % of assets Balance sheet 17.9% 14.0% 25 of 47
Change in share count Balance sheet 7.7% 0.9% 57 of 72
Days sales outstanding Balance sheet 41 days 58 days 18 of 62

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Broadband $204M 43.7% ▲ 75.0%
Infrastructure $148M 31.7% ▲ 30.1%
Connectivity $78M 16.7% ▲ 39.8%
Industrialandmultimarket $37.1M 7.9% ▼ 49.9%

From Maxlinear, Inc's 10-K filed January 29, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$9.5B
Institutions reporting
426
Shares held vs prior quarter
▼ 2.1%
Positions opened / closed
222 / 29

Top buyers and sellers, Q2 2026: 310 institutions bought and 131 sold ; the biggest buyer was Price T Rowe Associates Inc (+2.1M shares) and the biggest seller FMR LLC (−3.6M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.8B 13.7M 18.5% ▲ 2.2%
Vanguard Portfolio Management LLC $886M 6.9M 9.3% ▼ 24.4%
State Street Corp $554M 4.3M 5.8% ▼ 14.6%
Vanguard Capital Management LLC $489M 3.8M 5.2% ▲ 4.6%
Price T Rowe Associates Inc $285M 2.2M 3.0% ▲ 2241.8%
Geode Capital Management, LLC $285M 2.2M 3.0% ▲ 7.1%
Invesco Ltd. $262M 2.1M 2.8% ▼ 18.1%
Jane Street Group, LLC $262M 2.0M 2.8% ▲ 367.6%
D. E. Shaw & Co., Inc. $238M 1.9M 2.5% ▲ 7084.5%
Jpmorgan Chase & Co $235M 2.2M 2.5% ▲ 627.6%
FMR LLC $211M 1.7M 2.2% ▼ 68.6%
Manufacturers Life Insurance Company, The $165M 1.3M 1.7% ▼ 56.9%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Maxlinear, Inc's complete shareholder register. Values are as reported by the filers ; 4 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $60.1M 30 trades by 8 insiders · 1% under pre-set plans
Net ▼ $60.1M net selling
Insider Date Trade Shares Price Value
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 13,919 $87.12 $1.2M
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 71,163 $86.47 $6.2M
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 68,976 $85.43 $5.9M
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 17,766 $84.63 $1.5M
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 2,285 $88.14 $201,400
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 13,289 $87.11 $1.2M
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 72,298 $86.49 $6.3M
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 68,482 $85.44 $5.9M
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 3,903 $88.16 $344,088
Seendripu Kishore Chairman, President and CEO August 17, 2026 Sell 19,373 $84.65 $1.6M
Seendripu Kishore Chairman, President and CEO August 14, 2026 Sell 5,742 $84.86 $487,266
Seendripu Kishore Chairman, President and CEO August 14, 2026 Sell 77,515 $84.84 $6.6M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 2 trades and filings

No trades in Maxlinear, Inc disclosed in the last 12 months; 2 earlier trades on record.

  • Lamar Smith(TX):Purchase, $1,001 - $15,000, traded August 8, 2018, filed September 7, 2018
  • Lamar Smith(TX):Purchase, $1,001 - $15,000, traded January 18, 2017, filed February 9, 2017

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around January 28, 2027 estimated from the company's past filing pattern, not announced

  • October 22, 2026
  • July 23, 2026
  • April 23, 2026
  • January 29, 2026
  • October 23, 2025
  • July 23, 2025

Recent SEC filings

Data status

When each part of this page on Maxlinear, Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Maxlinear, Inc in brief

What does Maxlinear, Inc do?
Maxlinear, Inc is a US-listed company in the semiconductors industry. Its financial year ends in December.
What is Maxlinear, Inc's stock ticker?
Maxlinear, Inc trades under the ticker MXL on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Maxlinear, Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Maxlinear, Inc reported revenue of $661M, 56.0% higher than a year earlier, according to its SEC filings.
What is Maxlinear, Inc's free cash flow?
Maxlinear, Inc's free-cash-flow margin is -3.1% of revenue over the trailing twelve months, ranking 55 of the 75 semiconductor companies we cover.
Who are Maxlinear, Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Portfolio Management LLC and State Street Corp. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Maxlinear, Inc's market cap?
On November 2, 2026, Maxlinear, Inc's market capitalisation was about $5.7B and net debt of $83.9M. Market figures come from third-party market data and may be delayed.
How much debt does Maxlinear, Inc have?
Maxlinear, Inc's debt-to-equity ratio is 30.8%, from its latest balance sheet (54.2% five years earlier). The financial health section below sets out its other solvency checks.
Who are Maxlinear, Inc's competitors?
In our Semiconductors peer group, the companies closest to Maxlinear, Inc are Daqo NEW Energy Corp., Lattice Semiconductor Corp, Alpha & Omega Semiconductor Ltd, Chipmos Technologies Inc and Rambus Inc. The side-by-side comparison below sets their revenue, margins and growth against Maxlinear, Inc's.
Are insiders buying or selling Maxlinear, Inc stock?
Over the last 12 months, Maxlinear, Inc's directors and officers reported 0 open-market purchases and 30 sales on Form 4. The insider trading page charts every trade.
When is Maxlinear, Inc's next earnings date?
Around January 28, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Maxlinear, Inc announces its own schedule.